Skip to main content

Stefan Hummer

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Stefan Hummer

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

MNK - EB1

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Inés de Torres Ramirez, Adriana Martinez Cifuentes, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Vicente Peg Camara, Stefan Hummer
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 189970
Reference: SLT036/24/000026
Duration: 21/12/2024 - 20/12/2026

The MNK inhibitor EB1: a novel opportunity to combat therapy resistance in cancer treatment

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Inés de Torres Ramirez, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Vicente Peg Camara, Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 149347
Reference: 2024 PROD 00056
Duration: 02/12/2024 - 01/06/2026

inhibición de la comunicación celular para la prevención del desarrollo de metástasis y la resistencia a terapias antitumorales. Desarrollo de dos nuevas aproximaciones terapéuticas

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Josep Castellví Vives, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Javier Hernandez Losa, Marta Sese Faustino, Lourdes Elena Salazar Huayna, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 240000
Reference: PI23/01754
Duration: 01/01/2024 - 31/12/2026

Targeting the polyglutamylation enzyme TTLL11 - a novel strategy for cancer therapy (MITOCANCER)

IP: Stefan Hummer
Collaborators: -
Funding agency: Fundació Institut Bioenginyeria de Catalunya
Funding: 0.01
Reference: IBEC/2022/ HUMMER
Duration: 02/01/2023 - 31/12/2024

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Montserrat Perez Gonzalez

Montserrat Perez Gonzalez

Research technician
Clinical Pharmacology
Read more
Albert Gargallo Margarit

Albert Gargallo Margarit

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Sara Ajanovic Andelic

Sara Ajanovic Andelic

Predoctoral researcher
Infection and immunity in pediatric patients
Read more
Sabina Salicrú Riera

Sabina Salicrú Riera

Predoctoral researcher
Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.